Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13440433 | 0.79 | CA12 (0.46) | LMNAKDM4ECA12CA9CA2 | |
| SCHEMBL8369191 | 0.76 | CA12 (0.39) | LMNAKDM4ECA12CA9CA2 | |
| SCHEMBL529430 | 0.76 | CA12 (0.43) | LMNAKDM4ECA12CA9CA2 | |
| SCHEMBL1661224 | 0.76 | CA12 (0.46) | LMNAKDM4ECA12CA9CA2 | |
| SCHEMBL3807234 | 0.75 | CA12 (0.46) | LMNAKDM4ECA12CA9CA2 | |
| SCHEMBL18790752 | 0.75 | RET (0.53) | GABRA1GABRB2LMNAKDM4ECA12 | |
| SCHEMBL19666184 | 0.75 | CA12 (0.34) | LMNAKDM4ECA12CA9CA2 | |
| SCHEMBL3806455 | 0.74 | PTGER4 (0.47) | LMNAKDM4ECA12CA9CA2 | |
| SCHEMBL18762952 | 0.73 | GABRA1 (0.46) | GABRA1GABRB2LMNAKDM4ECA12 | |
| SCHEMBL230481 | 0.73 | CA9 (0.50) | LMNAKDM4ECA12CA9CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1980 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240230660-A1 | PROTEIN MELT ANALYSIS USING DIPYRROMETHENEBORON DIFLUORIDE COMPOUNDS | LIFE TECHNOLOGIES CORP (US) | 2024-07-11 | — | — | US | claimed |
| US-11883392-B2 | Pharmaceutical composition for nasal delivery | OREXO AB (SE) | 2024-01-30 | — | — | US | claimed |
| WO-2023249087-A1 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME | 三生医薬株式会社 | 2023-12-28 | — | — | WO | claimed |
| CN-114401775-B | Isolation of color body carotenoids from fruits | 卡利亚里大学 | 2023-11-07 | — | — | CN | claimed |
| CN-115836225-A | Detection of elements using sugar-lectin coupling | 伊鲁米纳公司 | 2023-03-21 | — | — | CN | claimed |
| EP-3996687-A1 | PHARMACEUTICAL COMPOSITION FOR NASAL DELIVERY | Orexo AB (SE) | 2022-05-18 | — | — | EP | claimed |
| CN-114401775-A | Isolation of chromoplast carotenoids from fruit | 卡利亚里大学 | 2022-04-26 | — | — | CN | claimed |
| CN-108342258-B | Liquid detergent composition | 花王株式会社 | 2022-04-01 | — | — | CN | claimed |
| US-20210401825-A1 | PHARMACEUTICAL COMPOSITION FOR NASAL DELIVERY | OREXO AB (SE) | 2021-12-30 | — | — | US | claimed |
| WO-2021050687-A1 | STABLE AQUEOUS FORMULATIONS OF AFLIBERCEPT | Coherus Biosciences, Inc. (US) | 2021-03-18 | — | — | WO | claimed |
| US-5372744-A | Shampoos; low irritant to skin and hair | KAO CORPORATION (JP) | 1994-12-13 | — | — | US | claimed |
| EP-0538762-A1 | Hair cosmetic | KAO CORPORATION (JP) | 1993-04-28 | — | — | EP | claimed |
| US-5057311-A | Mixture of alkyl saccharide surfactant and cationic polymer | KAO CORPORATION (JP) | 1991-10-15 | — | — | US | claimed |
| EP-0444778-A1 | Use of alkyl saccharides to enhance the penetration of drugs | ALCON LABORATORIES, INC. (US) | 1991-09-04 | — | — | EP | claimed |
| US-5015414-A | Polyoxyethylene modified saccharide blend with amphoteric surfactant | KAO CORPORATION (JP) | 1991-05-14 | — | — | US | claimed |
| EP-0422508-A2 | Liquid detergent composition | KAO CORPORATION (JP) | 1991-04-17 | — | — | EP | claimed |
| EP-0409005-A2 | Detergent composition | KAO CORPORATION (JP) | 1991-01-23 | — | — | EP | claimed |
| EP-0358216-A2 | Low-irritant detergent composition | Kao Corporation (JP) | 1990-03-14 | — | — | EP | claimed |
| US-4483979-A | Polar solvent extraction of colored materials from alkylsaccharides under essentially anhydrous conditions | THE PROCTER & GAMBLE COMPANY (US) | 1984-11-20 | — | — | US | claimed |
| US-4227911-A | PLANT GROWTH STIMULANTS AND ANTIFOULING AGENTS FOR SPRAYING DEVICES | CONKLIN COMPANY, INC. (US) | 1980-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240230660-A1 | PROTEIN MELT ANALYSIS USING DIPYRROMETHENEBORON DIFLUORIDE COMPOUNDS | PFDN6, S100A6, MB | GABRA1 2962/4885GABRB2 3620/4885LMNA 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.